Vice President, Strategic Program Direction

Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a biopharmaceutical company dedicated to creating new standards of care for patients.

We have strategically built a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune disease. Our portfolio encompasses a wide range of modalities, each with the potential to be best and/or first in class.

Anchored in a deep understanding of oncology, immunology, and translational medicine, we create differentiated ideas, identify the most appropriate targets, and select the optimal modality to develop transformative therapeutics across a wide variety of cancer and autoimmune indications.

We push conventional boundaries from candidate selection to differentiated therapeutic, applying rigorous go/no go criteria at each stage of development to fast-track only the most promising molecules to the clinic and, ultimately, commercialization.

With deep scientific expertise, our teams exercise creativity and urgency to deliver on our promise to bring new therapeutic solutions to patients.

Summary

The VP, Strategic Program Direction leads and drives the creation of integrated program strategies through engaging with and including information from all relevant stakeholders. As leader of one or more cross-functional asset-level project teams, the incumbent is responsible for program oversight and execution. The VP, Strategic Program Direction is also responsible for ensuring senior leadership has the right information, via discussion and presentations, to authorize final program strategy decisions.

Position Responsibilities

• Leads and inspires high-performing cross-functional matrix teams.
• Provide sound strategic guidance for asset-specific development strategies inclusive of research, clinical, regulatory, supply (includes tox, clinical and commercial materials) and commercial needs.
• Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans under their remit .
• Encourages broad cross functional perspective to develop program strategies including scientific rationale, operational feasibility, budget, timeline, and an understanding of the competitive and commercial landscape.
• Clearly communicates program risks, implications of changes in the competitive landscape, and progress toward key milestones .
• Leverages experience to drive team problem-solving in delivering key data and interpretation essential for robust debate and rapid and objective, data-driven decision making .
• Mentors and supports more junior colleagues in the clinical organization to refine asset-specific strategies beyond their direct remit and facilitate development of cross-functional team leadership skills.

Candidate Requirements

• MD, PhD, PharmD, or equivalent advanced degree of relevance.
• 10+ years of experience in the drug development process and leadership experience in academic or industry settings.
• Expertise in the end-to-end drug development process, especially late development space, relevant regulatory expectations, and overall drug development principles.
• Deep understanding of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology, including exposure-response relationships and dose selection in early development.
• Working knowledge of all functional areas of exploratory development (e.g., chemistry/biochemistry, CMC), late development, and commercial .
• Proven leadership capability with a successful track record of working within a matrixed environment and influencing across functional areas outside of direct line management.
• Ability to create a clear purpose, global vision, strategies, and key priorities for competing successfully in the evolving pharmaceutical and healthcare industry .
• Track-record of successfully mentoring junior colleagues and/or direct reports to succeed in positions of greater scope and authority.
• Demonstrated ability to successfully present complex programs to senior leaders and influence decision making
• Subject matter expertise in autoimmune disease and/or hematology/oncology development is desirable.

Cullinan Therapeutics is proud to be an Equal Opportunity Employer. We are committed to creating an inclusive and diverse environment for all employees and applicants without regard to a person’s race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.